Eiger obtains DSMB approval to progress Phase III Covid-19 therapy trial
21 Sep 2021 //
CLINICALTRIALSARENA
Eiger Announces FDA Breakthrough Therapy Designation for Peginterferon Lambda
20 Aug 2019 //
PR NEWSWIRE
Ascletis opens Clinical Development Shanghai Center
12 Aug 2019 //
BIOSPECTRUMASIA